Skip to main content
Tech.euFundingExplorerBeta

Biocross

Biocross is a biotechnology company develops blood tests for the diagnosis of Alzheimer’s disease.

Biocross has raised €450k across 1 funding round from 1 investor, most recently a round in Aug 2021. Based in Boecillo, Spain; active in Healthtech. Data as of 28 Oct 2026.

Boecillo, Spainwww.biocross.es ↗
Healthtech
← All companies
Total raised
€450k
€450,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-08
latest 2021-08

Funding by year

EUR raised per year
Biocross — funding by year — interactive chart.
Data table
Biocross — funding by year
2021€450k

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2021-08-30Other€450kCentre for the Development of Industrial Technology (CDTI)View deal →

Investors

1
Centre for the Development of Industrial Technology (CDTI)

Related news

Similar companies

same sector or country

Global coverage: FundingData